GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,508,000 | +103.2% | 36,829 | -4.6% | 0.02% | +100.0% |
| Q2 2022 | $1,234,000 | -36.7% | 38,620 | -49.5% | 0.01% | -36.8% |
| Q3 2021 | $1,949,000 | -31.7% | 76,497 | -6.2% | 0.02% | -24.0% |
| Q2 2021 | $2,855,000 | -37.3% | 81,511 | -27.1% | 0.02% | -43.2% |
| Q1 2021 | $4,556,000 | -5.2% | 111,795 | +0.8% | 0.04% | -18.5% |
| Q4 2020 | $4,804,000 | +11.3% | 110,910 | +41.7% | 0.05% | -15.6% |
| Q3 2020 | $4,315,000 | -17.8% | 78,251 | -5.9% | 0.06% | -8.6% |
| Q2 2020 | $5,248,000 | -6.0% | 83,128 | -23.9% | 0.07% | -18.6% |
| Q1 2020 | $5,581,000 | -42.2% | 109,237 | -10.0% | 0.09% | +14.7% |
| Q4 2019 | $9,648,000 | +66.2% | 121,371 | +1.4% | 0.08% | +66.7% |
| Q3 2019 | $5,805,000 | -6.2% | 119,641 | +1.7% | 0.04% | -2.2% |
| Q2 2019 | $6,190,000 | -12.8% | 117,672 | -12.3% | 0.05% | -8.0% |
| Q1 2019 | $7,099,000 | +34.8% | 134,123 | +4.5% | 0.05% | +22.0% |
| Q4 2018 | $5,268,000 | +50.5% | 128,325 | +39.3% | 0.04% | +78.3% |
| Q3 2018 | $3,500,000 | +3.6% | 92,112 | +23.3% | 0.02% | +4.5% |
| Q2 2018 | $3,377,000 | +13.3% | 74,716 | +21.1% | 0.02% | -8.3% |
| Q1 2018 | $2,980,000 | +56.4% | 61,706 | +27.4% | 0.02% | +84.6% |
| Q4 2017 | $1,905,000 | +42.6% | 48,423 | +12.6% | 0.01% | +44.4% |
| Q3 2017 | $1,336,000 | +24.0% | 43,015 | +9.3% | 0.01% | +12.5% |
| Q2 2017 | $1,077,000 | -19.9% | 39,366 | +7.9% | 0.01% | -11.1% |
| Q1 2017 | $1,345,000 | +159.7% | 36,492 | +1.8% | 0.01% | +125.0% |
| Q4 2016 | $518,000 | – | 35,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |